Updated: Jun 1, 2024
The average Travere Therapeutic stock price target is 15.20 with a max estimate of 21.00 and a min estimate of 9.00
Review Travere Therapeutic earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Jun 1, 2024